MADRID — New data from two randomized trials suggest that dual antiplatelet therapy (DAPT) should be significantly shortened or not used at all after coronary artery bypass surgery (CABG). Researchers ...
Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year after ...
MADRID, Spain—Adding ticagrelor on top of aspirin alone for 1 year does not lower the incidence of death, MI, stroke, or repeat revascularization in ACS patients who undergo CABG surgery, according to ...
MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results